zepbound/tirzepatide Zepbound From Eli Lilly and Company Zepbound® (Tirzepatide) Prescribed Online with

Weight regain following discontinuation of these medications is common (Figure 2), with up to two-thirds of weight loss being regained within the first year 24

Total monthly cost: scenario comparison The Bridge Program reduces monthly medication cost by roughly $1,000 compared to retail cash pay

Excluded or Cautioned Populations in Phase 3 Trials Phase 3 REDEFINE/REIMAGINE protocols typically excluded participants with: Type 1 diabetes

Safety is peptide, dose and delivery dependent

For our patients with a higher BMI , Semaglutide GLP-1 may offer greater benefits in terms of weight loss, glycemic control, and cardiovascular risk reduction compared to Liraglutide